Published on: April 27, 2018 at 12:00PM
Conditions: Colorectal Neoplasms; Chemotherapy
Interventions: Drug: XELIRI; Drug: XELOX
Sponsors: Harbin Medical University; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Fudan University; Sun Yat-sen University; First Affiliated Hospital of Harbin Medical University; The Second Affiliated Hospital of Harbin Medical University; Liaoning Tumor Hospital & Institute; Shengjing Hospital; First Hospital of Jilin University; The First Affiliated Hospital of Dalian Medical University; Jilin Provincial Tumor Hospital; The first affiliated hospital of Jinzhou Medical University
Recruiting
https://ift.tt/2jcW6DZ
No comments:
Post a Comment